Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Statement of Deviation or Variation, along with ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Limited has filed a quarterly compliance statement under SEBI Regulation 32 confirming no deviation or variation in the use of funds raised through a Preferential Issue of Warrants in November 2024. The total issue size was Rs. 40.86 crore (assuming full conversion of 58,37,143 warrants at Rs. 70 each). Out of this, Rs. 36.07 crore has been utilized till December 31, 2025, entirely for Working Capital and General Corporate Purposes as originally stated, leaving Rs. 4.79 crore pending utilization. The remaining funds were received progressively through 75% warrant-to-equity conversions across multiple tranches. The Auditor (Shah Kailash & Associates LLP) has certified the utilization with zero deviation, and the Audit Committee has reviewed and taken the statement on record.
This is a routine compliance confirmation and not a material event. It reassures shareholders that the Rs. 40.86 crore raised from the warrant issue is being used as promised (working capital purposes) with no misuse or diversion. Pending utilization of Rs. 4.79 crore is normal and reflects ongoing deployment; no price-moving signal for the stock.